In CD4+ T cells, the IL-33/ST2 signaling pathway plays an important role in Th2 activation, and interestingly, IL1RL1 variants are linked to increased risk of IL-33-driven type 2 inflammation in asthma [45]. The gene discussed is IL33; the disease is asthma.